FDA Inspection 1119005 — Simon Walsh MD
The FDA completed an inspection of Simon Walsh MD on February 6, 2020 in Belfast. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 6, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Belfast (United Kingdom)
Additional Details
Clinical Investigator (CI)